Prostate Cancer - Results from #25400

Effect of Diabetes Mellitus on High-grade Prostate Cancer Detection Among Japanese Obese Patients With Prostate-specific Antigen Less Than 10 ng/mL - Abstract July 20, 2012

Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial - Abstract July 20, 2012

Impact of Neoadjuvant Prostate-Specific Antigen Kinetics on Biochemical Failure and Prostate Cancer Mortality: Results From a Prospective Patient Database - Abstract July 20, 2012

Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation Therapy - Abstract July 20, 2012

Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News? - Abstract July 20, 2012

Patient Positioning Based on a Radioactive Tracer Implanted in Patients With Localized Prostate Cancer: A Performance and Safety Evaluation - Abstract July 20, 2012

Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer - Abstract July 19, 2012

Image guidance in the focal treatment of prostate cancer - Abstract July 19, 2012

Differential patterns of Large Tumor Antigen specific immune responsiveness in patients with BK polyomavirus positive prostate cancer or benign prostatic hyperplasia - Abstract July 19, 2012

BJUI Mini Reviews - Optimising repeat prostate biopsy decisions and procedures July 19, 2012

Predicting Survival for Surgery of Metastatic Spinal Cord Compression in Prostate Cancer: A New Score - Abstract July 19, 2012

[Multiparametric MRI, elastography, contrastenhanced TRUS : Are there indications with reliable diagnostic advantages before prostate biopsy?] - Abstract July 19, 2012

Selenium and prostate cancer: systematic review and meta-analysis - Abstract July 19, 2012

Proton beam radiotherapy in the U.S. Medicare population: growth in use between 2006 and 2009: Data Points # 10 - Abstract July 19, 2012

Low-dose chemotherapy with insulin (insulin potentiation therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer - Abstract July 19, 2012

Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy - Abstract July 19, 2012

A systematic review of the role of adjuvant and neoadjuvant pharmacotherapy in patients undergoing radical prostatectomy - Abstract July 18, 2012

Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation - Abstract July 18, 2012

Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients - Abstract July 18, 2012

Managing side effects of the novel taxane cabazitaxel in castrate-resistant prostate cancer - Abstract July 18, 2012

Page 1271 of 1437